Roflumilast: a review of its use in the treatment of COPD
Jadwiga A Wedzicha,1 Peter MA Calverley,2 Klaus F Rabe3,41Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, 2Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK; 3Department of Internal Medicine, Christian-Albrechts University, K...
Main Authors: | Wedzicha JA, Calverley PMA, Rabe KF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-01-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/roflumilast-a-review-of-its-use-in-the-treatment-of-copd-peer-reviewed-article-COPD |
Similar Items
-
Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment
by: Ita Octafia, et al.
Published: (2021-01-01) -
Roflumilast: Review of Phosphodiesterase-4 Inhibitor as Asthma Therapy
by: Rafina Syfridiana, et al.
Published: (2021-08-01) -
The Dosing Strategy to Improve Adherence to Roflumilast in Treatment for Chronic Obstructive Lung Disease: A Systemic Review and Meta-Analysis
by: Lee J, et al.
Published: (2024-03-01) -
Roflumilast – a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD
by: Anne B Taegtmeyer, et al.
Published: (2012-07-01) -
COPD, stage and treatment in a large outpatient clinic
by: Claire Præst Holm, et al.
Published: (2017-01-01)